Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014282 · ClinicalTrials.gov registry record · NA
Automated Video-Assisted Smoking Treatment for People Living With HIV
A NA study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 638
- Enrollment target
- 1
- Study location
NCT05014282: Active NA study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT05014282 is a NA study of Smoking Cessation that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 638 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05014282, a NA study of Smoking Cessation, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 638 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate if Automated Treatment performs better, in terms of facilitating long-term smoking abstinence, than the more resource-intensive Standard Treatment.
Primary Outcome
Participants will self report 7-day abstinence smoking status
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- DRUG Nicotine patch
- DRUG Nicotine lozenge
- BEHAVIORAL Smartphone-delivered automated treatment
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 638 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2026-09-23 |
| Phase | NA |
What the registry record for NCT05014282 still lists
NCT05014282 is an interventional study that assigns participants to a tested intervention. The registered 638 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (35% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Counseling is the first listed.
NCT05014282 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05014282 about?
NCT05014282 is a clinical study titled "Automated Video-Assisted Smoking Treatment for People Living With HIV". This study will evaluate if Automated Treatment performs better, in terms of facilitating long-term smoking abstinence, than the more resource-intensive Standard Treatment.
What is the current status of trial NCT05014282?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 638 participants. The study started on 2021-12-15. Estimated completion is 2026-09-23.
What conditions does trial NCT05014282 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT05014282?
The interventions under investigation include: Counseling (BEHAVIORAL), Nicotine patch (DRUG), Nicotine lozenge (DRUG), Smartphone-delivered automated treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05014282?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014282 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05014282's enrollment target sits among peer trials
638 43rd of 188 higher than 146 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI